<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.biomedcentral.com/feeds/editorspicks?journal=bmcresnotes&amp;quantity=">
        <title>Editor's picks</title>
        <link>http://www.biomedcentral.com/bmcresnotes/</link>
        <description>The editor's pick of recent articles published by BMC Research Notes</description>
        <dc:date>2012-05-09T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.biomedcentral.com/content/5/1/223" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1756-0500/5/127" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1756-0500/5/119" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1756-0500/5/111" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1756-0500/5/88" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1756-0500/5/10" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1756-0500/5/2" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1756-0500/4/524" />
                            </rdf:Seq>
        </items>
                 <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.biomedcentral.com/content/5/1/223">
        <title>Adventures in data citation: sorghum genome data exemplifies the new gold standard</title>
        <description>Scientific progress is driven by the availability of information, which makes it essential that data be broadly, easily and rapidly accessible to researchers in every field. In addition to being good scientific practice, provision of supporting data in a convenient way increases experimental transparency and improves research efficiency by reducing unnecessary duplication of experiments. There are, however, serious constraints that limit extensive data dissemination. One such constraint is that, despite providing a major foundation of data to the advantage of entire community, data producers rarely receive the credit they deserve for the substantial amount of time and effort they spend creating these resources. In this regard, a formal system that provides recognition for data producers would serve to incentivize them to share more of their data.The process of data citation, in which the data themselves are cited and referenced in journal articles as persistently identifiable bibliographic entities, is a potential way to properly acknowledge data output. The recent publication of several sorghum genomes in Genome Biology is a notable first example of good data citation practice in the field of genomics and demonstrates the practicalities and formatting required for doing so. It also illustrates how effective use of persistent identifiers can augment the submission of data to the current standard scientific repositories.</description>
        <link>http://www.biomedcentral.com/content/5/1/223</link>
                <dc:creator>Scott C Edmunds</dc:creator>
                <dc:creator>Tom J Pollard</dc:creator>
                <dc:creator>Brian Hole</dc:creator>
                <dc:creator>Alexandra Basford</dc:creator>
                <dc:source>BMC Research Notes 2012, 5:223</dc:source>
        <dc:date>2012-05-09T00:00:00Z</dc:date>
        <dc:identifier>10.1186/1756-0500-5-223</dc:identifier>
                            <dc:title>Dataset citation: setting a new gold standard</dc:title>
                            <dc:description>Editor of Giga Science, Scott Edmunds et al. discuss using Digital Object Identifiers (DOI) to make published datasets citable, encouraging authors to make their work publically available to the scientific community.</dc:description>
                <prism:require>/content/figures/1756-0500-5-223-toc.gif</prism:require>
                <prism:publicationName>BMC Research Notes</prism:publicationName>
        <prism:issn>1756-0500</prism:issn>
        <prism:volume>5</prism:volume>
        <prism:startingPage>223</prism:startingPage>
        <prism:publicationDate>2012-05-09T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1756-0500/5/127">
        <title>Taking alcohol by deception: an analysis of ethanol concentration of &quot;paraga&quot; an alcoholic herbal mixture in Nigeria</title>
        <description>Background:
Alcohol related road traffic injuries are on the rise in Nigeria. A sizable proportion of the alcohol intake is disguised as herbal medicines which are commonly available at motor parks in most urban centres. This study aims to determine the ethanol concentration of the herbal preparations and the vendors&apos; knowledge about their preparation and use. Twenty-eight samples of the paraga mixtures were obtained for analysis from 22 paraga vendors. The vendors were interviewed in the motor parks using a semi-structured questionnaire.
Results:
All the paraga outlets were located in or near motor parks. Commercial motor drivers and motorcyclists accounted for most customers. There were no formal recipes, production involved no calibrations or weighing and thus the components and concentration of different batches varied. The alcohol by volume (ABV) of the samples ranged between 1.20% and 20.84%. Nine samples were weaker than beers (Alcohol By Volume (ABV) of 1-3.1%). Ten were equivalent to beer (ABV:3-8%) and the rest were equivalent to wine (ABV:8-12%) or stronger (ABV: 18-20%).
Conclusions:
Paraga should be classified as alcoholic beverages, and its sale restricted as such. The production should come under scrutiny, because the haphazard ways they are prepared may pose other health risks apart from those due to their alcoholic contents.</description>
        <link>http://www.biomedcentral.com/1756-0500/5/127</link>
                <dc:creator>Oluwadiya S Kehinde</dc:creator>
                <dc:creator>Akinola E Adegoke</dc:creator>
                <dc:source>BMC Research Notes 2012, 5:127</dc:source>
        <dc:date>2012-03-06T00:00:00Z</dc:date>
        <dc:identifier>10.1186/1756-0500-5-127</dc:identifier>
                            <dc:title>An alcoholic herbal remedy sold to motorists</dc:title>
                            <dc:description>&apos;Paraga&apos;, a legal herbal remedy common in Nigeria and sold at motor parks, has alcohol levels similar to beer and wine but is not currently classified as an alcoholic beverage</dc:description>
                <prism:require>/content/figures/1756-0500-5-127-toc.gif</prism:require>
                <prism:publicationName>BMC Research Notes</prism:publicationName>
        <prism:issn>1756-0500</prism:issn>
        <prism:volume>5</prism:volume>
        <prism:startingPage>127</prism:startingPage>
        <prism:publicationDate>2012-03-06T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1756-0500/5/119">
        <title>A mobile phone based alarm system for supervising vital parameters in free moving rats</title>
        <description>Background:
Study protocols involving experimental animals often require the monitoring of different parameters not only in anesthetized, but also in free moving animals. Most animal research involves small rodents, in which continuously monitoring parameters such as temperature and heart rate is very stressful for the awake animals or simply not possible. Aim of the underlying study was to monitor heart rate, temperature and activity and to assess inflammation in the heart, lungs, liver and kidney in the early postoperative phase after experimental cardiopulmonary bypass involving 45 min of deep hypothermic circulatory arrest in rats. Besides continuous monitoring of heart rate, temperature and behavioural activity, the main focus was on avoiding uncontrolled death of an animal in the early postoperative phase in order to harvest relevant organs before autolysis would render them unsuitable for the assessment of inflammation.FindingsWe therefore set up a telemetry-based system (Data Science International, DSI&#8482;) that continuously monitored the rat&apos;s temperature, heart rate and activity in their cages. The data collection using telemetry was combined with an analysis software (Microsoft excel&#8482;), a webmail application (GMX) and a text message-service. Whenever an animal&apos;s heart rate dropped below the pre-defined threshold of 150 beats per minute (bpm), a notification in the form of a text message was automatically sent to the experimenter&apos;s mobile phone. With a positive predictive value of 93.1% and a negative predictive value of 90.5%, the designed surveillance and alarm system proved a reliable and inexpensive tool to avoid uncontrolled death in order to minimize suffering and harvest relevant organs before autolysis would set in.
Conclusions:
This combination of a telemetry-based system and software tools provided us with a reliable notification system of imminent death. The system&apos;s high positive predictive value helped to avoid uncontrolled death and facilitated timely organ harvesting. Additionally we were able to markedly reduce the drop out rate of experimental animals, and therefore the total number of animals used in our study. This system can be easily adapted to different study designs and prove a helpful tool to relieve stress and more importantly help to reduce animal numbers.</description>
        <link>http://www.biomedcentral.com/1756-0500/5/119</link>
                <dc:creator>Kristine Kellermann</dc:creator>
                <dc:creator>Matthias Kreuzer</dc:creator>
                <dc:creator>Adem Omerovich</dc:creator>
                <dc:creator>Franziska Hoetzinger</dc:creator>
                <dc:creator>Eberhard F Kochs</dc:creator>
                <dc:creator>Bettina Jungwirth</dc:creator>
                <dc:source>BMC Research Notes 2012, 5:119</dc:source>
        <dc:date>2012-02-23T00:00:00Z</dc:date>
        <dc:identifier>10.1186/1756-0500-5-119</dc:identifier>
                            <dc:title>Remote monitoring of experimental animals</dc:title>
                            <dc:description>A mobile phone based alarm system allows researchers to remotely monitor heart rate, temperature and activity of experimental rats, this may lead to lower animal stress levels and reduced numbers for many studies.</dc:description>
                <prism:require>/content/figures/1756-0500-5-119-toc.gif</prism:require>
                <prism:publicationName>BMC Research Notes</prism:publicationName>
        <prism:issn>1756-0500</prism:issn>
        <prism:volume>5</prism:volume>
        <prism:startingPage>119</prism:startingPage>
        <prism:publicationDate>2012-02-23T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1756-0500/5/111">
        <title>An ovary transcriptome for all maturational stages of the striped bass (&lt;it&gt;Morone saxatilis&lt;/it&gt;), a highly advanced perciform fish</title>
        <description>Background:
The striped bass and its relatives (genus Morone) are important fisheries and aquaculture species native to estuaries and rivers of the Atlantic coast and Gulf of Mexico in North America. To open avenues of gene expression research on reproduction and breeding of striped bass, we generated a collection of expressed sequence tags (ESTs) from a complementary DNA (cDNA) library representative of their ovarian transcriptome.
Results:
Sequences of a total of 230,151 ESTs (51,259,448 bp) were acquired by Roche 454 pyrosequencing of cDNA pooled from ovarian tissues obtained at all stages of oocyte growth, at ovulation (eggs), and during preovulatory atresia. Quality filtering of ESTs allowed assembly of 11,208 high-quality contigs &#8805; 100 bp, including 2,984 contigs 500 bp or longer (average length 895 bp). Blastx comparisons revealed 5,482 gene orthologues (E-value &lt; 10-3), of which 4,120 (36.7% of total contigs) were annotated with Gene Ontology terms (E-value &lt; 10-6). There were 5,726 remaining unknown unique sequences (51.1% of total contigs). All of the high-quality EST sequences are available in the National Center for Biotechnology Information (NCBI) Short Read Archive (GenBank: SRX007394). Informative contigs were considered to be abundant if they were assembled from groups of ESTs comprising &#8805; 0.15% of the total short read sequences (&#8805; 345 reads/contig). Approximately 52.5% of these abundant contigs were predicted to have predominant ovary expression through digital differential display in silico comparisons to zebrafish (Danio rerio) UniGene orthologues. Over 1,300 Gene Ontology terms from Biological Process classes of Reproduction, Reproductive process, and Developmental process were assigned to this collection of annotated contigs.
Conclusions:
This first large reference sequence database available for the ecologically and economically important temperate basses (genus Morone) provides a foundation for gene expression studies in these species. The predicted predominance of ovary gene expression and assignment of directly relevant Gene Ontology classes suggests a powerful utility of this dataset for analysis of ovarian gene expression related to fundamental questions of oogenesis. Additionally, a high definition Agilent 60-mer oligo ovary &apos;UniClone&apos; microarray with 8 &#215; 15,000 probe format has been designed based on this striped bass transcriptome (eArray Group: Striper Group, Design ID: 029004).</description>
        <link>http://www.biomedcentral.com/1756-0500/5/111</link>
                <dc:creator>Benjamin J Reading</dc:creator>
                <dc:creator>Robert W Chapman</dc:creator>
                <dc:creator>Jennifer E Schaff</dc:creator>
                <dc:creator>Elizabeth H Scholl</dc:creator>
                <dc:creator>Charles H Opperman</dc:creator>
                <dc:creator>Craig V Sullivan</dc:creator>
                <dc:source>BMC Research Notes 2012, 5:111</dc:source>
        <dc:date>2012-02-21T00:00:00Z</dc:date>
        <dc:identifier>10.1186/1756-0500-5-111</dc:identifier>
                            <dc:title>A reference sequence database for temperate basses</dc:title>
                            <dc:description>A database of expressed sequence tags (ESTs) representative of Morone spp. ovarian transcriptome has been generated, this may be useful for gene expression research into these ecologically and economically important species.</dc:description>
                <prism:require>/content/figures/1756-0500-5-111-toc.gif</prism:require>
                <prism:publicationName>BMC Research Notes</prism:publicationName>
        <prism:issn>1756-0500</prism:issn>
        <prism:volume>5</prism:volume>
        <prism:startingPage>111</prism:startingPage>
        <prism:publicationDate>2012-02-21T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1756-0500/5/88">
        <title>Evolution of the eukaryotic ARP2/3 activators of the WASP family: WASP, WAVE, WASH, and WHAMM, and the proposed new family members WAWH and WAML</title>
        <description>Background:
WASP family proteins stimulate the actin-nucleating activity of the ARP2/3 complex. They include members of the well-known WASP and WAVE/Scar proteins, and the recently identified WASH and WHAMM proteins. WASP family proteins contain family specific N-terminal domains followed by proline-rich regions and C-terminal VCA domains that harbour the ARP2/3-activating regions.
Results:
To reveal the evolution of ARP2/3 activation by WASP family proteins we performed a &quot;holistic&quot; analysis by manually assembling and annotating all homologs in most of the eukaryotic genomes available. We have identified two new families: the WAML proteins (WASP and MIM like), which combine the membrane-deforming and actin bundling functions of the IMD domains with the ARP2/3-activating VCA regions, and the WAWH protein (WASP without WH1 domain) that have been identified in amoebae, Apusozoa, and the anole lizard. Surprisingly, with one exception we did not identify any alternative splice forms for WASP family proteins, which is in strong contrast to other actin-binding proteins like Ena/VASP, MIM, or NHS proteins that share domains with WASP proteins.
Conclusions:
Our analysis showed that the last common ancestor of the eukaryotes must have contained a homolog of WASP, WAVE, and WASH. Specific families have subsequently been lost in many taxa like the WASPs in plants, algae, Stramenopiles, and Euglenozoa, and the WASH proteins in fungi. The WHAMM proteins are metazoa specific and have most probably been invented by the Eumetazoa. The diversity of WASP family proteins has strongly been increased by many species- and taxon-specific gene duplications and multimerisations. All data is freely accessible via http://www.cymobase.org.</description>
        <link>http://www.biomedcentral.com/1756-0500/5/88</link>
                <dc:creator>Martin Kollmar</dc:creator>
                <dc:creator>Dawid Lbik</dc:creator>
                <dc:creator>Stefanie Enge</dc:creator>
                <dc:source>BMC Research Notes 2012, 5:88</dc:source>
        <dc:date>2012-02-08T00:00:00Z</dc:date>
        <dc:identifier>10.1186/1756-0500-5-88</dc:identifier>
                            <dc:title>Evolution of WASP family proteins</dc:title>
                            <dc:description>A homolog of the WASP protein family, important in actin cytoskeleton dynamics, was present in the last common ancestor of eukaryotes according to phylogenetic analysis of over 400 eukaryotic species.</dc:description>
                <prism:require>/content/figures/1756-0500-5-88-toc.gif</prism:require>
                <prism:publicationName>BMC Research Notes</prism:publicationName>
        <prism:issn>1756-0500</prism:issn>
        <prism:volume>5</prism:volume>
        <prism:startingPage>88</prism:startingPage>
        <prism:publicationDate>2012-02-08T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1756-0500/5/10">
        <title>Guidelines for information about therapy experiments: a proposal on best practice for recording experimental data on cancer therapy</title>
        <description>Background:
Biology, biomedicine and healthcare have become data-driven enterprises, where scientists and clinicians need to generate, access, validate, interpret and integrate different kinds of experimental and patient-related data. Thus, recording and reporting of data in a systematic and unambiguous fashion is crucial to allow aggregation and re-use of data. This paper reviews the benefits of existing biomedical data standards and focuses on key elements to record experiments for therapy development. Specifically, we describe the experiments performed in molecular, cellular, animal and clinical models. We also provide an example set of elements for a therapy tested in a phase I clinical trial.FindingsWe introduce the Guidelines for Information About Therapy Experiments (GIATE), a minimum information checklist creating a consistent framework to transparently report the purpose, methods and results of the therapeutic experiments. A discussion on the scope, design and structure of the guidelines is presented, together with a description of the intended audience. We also present complementary resources such as a classification scheme, and two alternative ways of creating GIATE information: an electronic lab notebook and a simple spreadsheet-based format. Finally, we use GIATE to record the details of the phase I clinical trial of CHT-25 for patients with refractory lymphomas. The benefits of using GIATE for this experiment are discussed.
Conclusions:
While data standards are being developed to facilitate data sharing and integration in various aspects of experimental medicine, such as genomics and clinical data, no previous work focused on therapy development. We propose a checklist for therapy experiments and demonstrate its use in the 131Iodine labeled CHT-25 chimeric antibody cancer therapy. As future work, we will expand the set of GIATE tools to continue to encourage its use by cancer researchers, and we will engineer an ontology to annotate GIATE elements and facilitate unambiguous interpretation and data integration.</description>
        <link>http://www.biomedcentral.com/1756-0500/5/10</link>
                <dc:creator>Alejandra N González-Beltrán</dc:creator>
                <dc:creator>May Y Yong</dc:creator>
                <dc:creator>Gairin Dancey</dc:creator>
                <dc:creator>Richard Begent</dc:creator>
                <dc:source>BMC Research Notes 2012, 5:10</dc:source>
        <dc:date>2012-01-06T00:00:00Z</dc:date>
        <dc:identifier>10.1186/1756-0500-5-10</dc:identifier>
                            <dc:title>New guidelines for reporting experimental therapies</dc:title>
                            <dc:description>As part of our thematic series, Richard Begent and colleagues present recommendations for creating an information checklist to provide a consistent framework for transparently reporting the results of therapeutic experiments.</dc:description>
                <prism:require>/content/figures/1756-0500-5-10-toc.gif</prism:require>
                <prism:publicationName>BMC Research Notes</prism:publicationName>
        <prism:issn>1756-0500</prism:issn>
        <prism:volume>5</prism:volume>
        <prism:startingPage>10</prism:startingPage>
        <prism:publicationDate>2012-01-06T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1756-0500/5/2">
        <title>The association between active participation in a sports club, physical activity and social network on the development of lung cancer in smokers: a case-control study</title>
        <description>Background:
This study analyses the effect of active participation in a sports club, physical activity and social networks on the development of lung cancer in patients who smoke. Our hypothesis is that study participants who lack social networks and do not actively participate in a sports club are at a greater risk for lung cancer than those who do.
Methods:
Data for the study were taken from the Cologne Smoking Study (CoSmoS), a retrospective case-control study examining potential psychosocial risk factors for the development of lung cancer. Our sample consisted of n = 158 participants who had suffered lung cancer (diagnosis in the patient document) and n = 144 control group participants. Both groups had a history of smoking.Data on social networks were collected by asking participants whether they participated in a sports club and about the number of friends and relatives in their social environment. In addition, sociodemographic data (gender, age, education, marital status, residence and religion), physical activity and data on pack years (the cumulative number of cigarettes smoked by an individual, calculated by multiplying the number of cigarettes smoked per day by the number of years the person has smoked divided by 20) were collected to control for potential confounders. Logistic regression was used for the statistical analysis.
Results:
The results reveal that participants who are physically active are at a lower risk of lung cancer than those who are not (adjusted OR = 0.53*; CI = 0.29-0.97). Older age and lower education seem also to be risk factors for the development of lung cancer. The extent of smoking, furthermore, measured by pack years is statistically significant. Active participation in a sports club, number of friends and relatives had no statistically significant influence on the development of the cancer.
Conclusions:
The results of the study suggest that there is a lower risk for physically active participants to develop lung cancer. In the study sample, physical activity seemed to have a greater protective effect than participation in a sports club or social network of friends and relatives. Further studies have to investigate in more detail physical activity and other club participations.</description>
        <link>http://www.biomedcentral.com/1756-0500/5/2</link>
                <dc:creator>Anna Schmidt</dc:creator>
                <dc:creator>Julia Jung</dc:creator>
                <dc:creator>Nicole Ernstmann</dc:creator>
                <dc:creator>Elke Driller</dc:creator>
                <dc:creator>Melanie Neumann</dc:creator>
                <dc:creator>Andrea Staratschek-Jox</dc:creator>
                <dc:creator>Christian Schneider</dc:creator>
                <dc:creator>Jürgen Wolf</dc:creator>
                <dc:creator>Holger Pfaff</dc:creator>
                <dc:source>BMC Research Notes 2012, 5:2</dc:source>
        <dc:date>2012-01-04T00:00:00Z</dc:date>
        <dc:identifier>10.1186/1756-0500-5-2</dc:identifier>
                            <dc:title>No psychosocial links to lung cancer risk</dc:title>
                            <dc:description>Active participation in a sports club and size of social network aren&apos;t associated with lung cancer risk, however ex-smokers who are physically active are at lower cancer risk than those who don&apos;t exercise.</dc:description>
                <prism:require>/content/figures/1756-0500-5-2-toc.gif</prism:require>
                <prism:publicationName>BMC Research Notes</prism:publicationName>
        <prism:issn>1756-0500</prism:issn>
        <prism:volume>5</prism:volume>
        <prism:startingPage>2</prism:startingPage>
        <prism:publicationDate>2012-01-04T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1756-0500/4/524">
        <title>The Netherlands study of depression in older persons (NESDO); a prospective cohort study</title>
        <description>Background:
To study late-life depression and its unfavourable course and co morbidities in The Netherlands.
Methods:
We designed the Netherlands Study of Depression in Older Persons (NESDO), a multi-site naturalistic prospective cohort study which makes it possible to examine the determinants, the course and the consequences of depressive disorders in older persons over a period of six years, and to compare these with those of depression earlier in adulthood.
Results:
From 2007 until 2010, the NESDO consortium has recruited 510 depressed and non depressed older persons (&#8805; 60 years) at 5 locations throughout the Netherlands. Depressed persons were recruited from both mental health care institutes and general practices in order to include persons with late-life depression in various developmental and severity stages. Non-depressed persons were recruited from general practices. The baseline assessment included written questionnaires, interviews, a medical examination, cognitive tests and collection of blood and saliva samples. Information was gathered about mental health outcomes and demographic, psychosocial, biological, cognitive and genetic determinants. The baseline NESDO sample consists of 378 depressed (according to DSM-IV criteria) and 132 non-depressed persons aged 60 through 93 years. 95% had a major depression and 26.5% had dysthymia. Mean age of onset of the depressive disorder was around 49 year. For 33.1% of the depressed persons it was their first episode. 41.0% of the depressed persons had a co morbid anxiety disorder. Follow up assessments are currently going on with 6 monthly written questionnaires and face-to-face interviews after 2 and 6 years.
Conclusions:
The NESDO sample offers the opportunity to study the neurobiological, psychosocial and physical determinants of depression and its long-term course in older persons. Since largely similar measures were used as in the Netherlands Study of Depression and Anxiety (NESDA; age range 18-65 years), data can be pooled thus creating a large longitudinal database of clinically depressed persons with adequate power and a large set of neurobiological, psychosocial and physical variables from both younger and older depressed persons.</description>
        <link>http://www.biomedcentral.com/1756-0500/4/524</link>
                <dc:creator>Hannie C Comijs</dc:creator>
                <dc:creator>Harm W van Marwijk</dc:creator>
                <dc:creator>Roos C van der Mast</dc:creator>
                <dc:creator>Paul Naarding</dc:creator>
                <dc:creator>Richard C Oude Voshaar</dc:creator>
                <dc:creator>Aartjan TF Beekman</dc:creator>
                <dc:creator>Marjolein Boshuisen</dc:creator>
                <dc:creator>Janny Dekker</dc:creator>
                <dc:creator>Rob Kok</dc:creator>
                <dc:creator>Margot WM de Waal</dc:creator>
                <dc:creator>Brenda WJH Penninx</dc:creator>
                <dc:creator>Max L Stek</dc:creator>
                <dc:creator>Johannes H Smit</dc:creator>
                <dc:source>BMC Research Notes 2011, 4:524</dc:source>
        <dc:date>2011-12-05T00:00:00Z</dc:date>
        <dc:identifier>10.1186/1756-0500-4-524</dc:identifier>
                            <dc:title>The course of late-life depression</dc:title>
                            <dc:description>The determinants and long term effects of depression in the elderly identified in the Netherlands Study of Depression in Older persons will allow comparison with studies of younger adults.</dc:description>
                <prism:require>/content/figures/1756-0500-4-524-toc.gif</prism:require>
                <prism:publicationName>BMC Research Notes</prism:publicationName>
        <prism:issn>1756-0500</prism:issn>
        <prism:volume>4</prism:volume>
        <prism:startingPage>524</prism:startingPage>
        <prism:publicationDate>2011-12-05T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>

